ANL 16.20 Decreased By ▼ -0.18 (-1.1%)
ASC 14.63 Increased By ▲ 0.95 (6.94%)
ASL 20.04 Decreased By ▼ -0.41 (-2%)
BOP 8.55 Decreased By ▼ -0.05 (-0.58%)
BYCO 7.53 Increased By ▲ 0.24 (3.29%)
FCCL 17.50 Increased By ▲ 0.11 (0.63%)
FFBL 23.15 Increased By ▲ 1.68 (7.82%)
FFL 15.25 Increased By ▲ 0.35 (2.35%)
FNEL 7.35 Increased By ▲ 0.05 (0.68%)
GGGL 17.15 Increased By ▲ 0.74 (4.51%)
GGL 29.95 Increased By ▲ 0.10 (0.34%)
HUMNL 5.96 Increased By ▲ 0.17 (2.94%)
JSCL 20.68 Increased By ▲ 0.28 (1.37%)
KAPCO 28.99 Increased By ▲ 0.31 (1.08%)
KEL 3.48 Increased By ▲ 0.03 (0.87%)
MDTL 2.11 Decreased By ▼ -0.09 (-4.09%)
MLCF 33.60 Increased By ▲ 0.18 (0.54%)
NETSOL 106.00 Decreased By ▼ -1.55 (-1.44%)
PACE 4.33 Decreased By ▼ -0.17 (-3.78%)
PAEL 27.95 Increased By ▲ 0.75 (2.76%)
PIBTL 8.70 Increased By ▲ 0.10 (1.16%)
POWER 6.90 Decreased By ▼ -0.03 (-0.43%)
PRL 17.18 Increased By ▲ 0.87 (5.33%)
PTC 9.30 Increased By ▲ 0.12 (1.31%)
SILK 1.44 No Change ▼ 0.00 (0%)
SNGP 42.33 Increased By ▲ 0.27 (0.64%)
TELE 16.45 Decreased By ▼ -0.09 (-0.54%)
TRG 135.78 Decreased By ▼ -2.22 (-1.61%)
UNITY 29.90 Increased By ▲ 1.40 (4.91%)
WTL 2.40 Decreased By ▼ -0.05 (-2.04%)
BR100 4,668 Increased By ▲ 50.21 (1.09%)
BR30 20,892 Increased By ▲ 107.28 (0.52%)
KSE100 44,822 Increased By ▲ 487.85 (1.1%)
KSE30 17,521 Increased By ▲ 178.45 (1.03%)

Coronavirus
LOW Source: covid.gov.pk
Pakistan Deaths
28,269
1724hr
Pakistan Cases
1,264,384
72024hr
1.61% positivity
Sindh
465,486
Punjab
437,793
Balochistan
33,120
Islamabad
106,445
KPK
176,774
Pakistan

Pharma firm Searle to supply Remedesvir drug in Pakistan to combat coronavirus

Beximco is the first company in the world who developed and introduced generic Remdesivir for the treatment of COVI
29 May 2020
  • Beximco is the first company in the world who developed and introduced generic Remdesivir for the treatment of COVID-19.
  • The partnership will provide an immediate supply of the finished product at an affordable price and will help health care providers of Pakistan to treat their hospitalized COVID-19 patients.

Pharmaceutical firm Searle will supply Remedesvir drug in Pakistan after the company announced that it has entered an agreement with Bangladesh’s firm Beximco Pharmaceuticals.

“The Searle Company Limited has successfully entered into an exclusive licensing and marketing agreement with Beximco Pharmaceuticals, Bangladesh,” announced the company in its filing to the Pakistan Stock Exchange (PSX) on Friday.

Beximco is the first company in the world who developed and introduced generic Remdesivir for the treatment of COVID-19. “Remdesivir is a direct-acting viral drug that inhibits viral RNA synthesis. It is administrated intravenously and is authorized for the treatment of hospitalized patients with severe COVID-19 disease.”

The company informed that the partnership will provide an immediate supply of the finished product at an affordable price and will help health care providers of Pakistan to treat their hospitalized COVID-19 patients without any delay. Searle said that it is initially planning to import Remdesivir in finished form (ready to use) to meet the country’s urgent requirements.

“Searle is actively taking the matter to the relevant authorities of Pakistan for necessary regulatory approval, Searle is confident that in the existing pandemic, the relevant authorities will consider the matter on an urgent basis to support the product availability n fastest track.”

The company added that it is also planning to donate a sizeable quantity of the drug to the Government of Pakistan.

 

 

Comments

Comments are closed.